NCT06319170 · Interventional trial
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
Overall registry status Completed
Phase 1
Conditions Schizophrenia, Schizoaffective Disorder
Delaware Valley sites
- Teva Investigational Site 15726 · Marlton, NJ · Burlington County
First posted
Registry updated
Added to the directory